Search for Sanofi and
    1. October 16, 2014

      Pharma giants face developing market ambitions

      As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

    2. October 9, 2014

      Sanofi hopes for substantial reward as dengue drug unveiled

      For big pharma, tackling neglected tropical diseases is a largely philanthropic enterprise – something done to demonstrate...

    Special Reports

    1. Combating Diabetes

      With the number of cases predicted to reach 592m worldwide by 2013, tackling the condi...
    2. Combating Neglected Diseases

      While nobody questions the horror of the Ebola epidemic sweeping west Africa, the deat...
    Search more Special Reports on this topic.

    1. beyondbrics

      August 21, 2014

      Legal hodge-podge frustrates Asean harmonisation

      Of all the colonial legacies left by Britain, France and the Netherlands in Asia, one of the least talked-about – yet...

    2. August 11, 2014

      Tesla powered higher by expansion plans

      Tesla shares approached an all-time high after brokerage Deutsche Bank lifted its rating on the electric car manufacturer to...

    3. August 6, 2014

      Sanofi’s success shows benefit of global approach in drugs R&D

      For reasons of prestige as much as profitability, every big pharmaceutical company wants to be known for expanding the...

    4. August 3, 2014

      Private equity eyes drug brands purchase

      Private equity groups are exploring a $10bn plan to buy hundreds of older drug brands from GlaxoSmithKline and Sanofi and...

    5. July 31, 2014

      Sanofi predicts ‘wave’ of new drug launches

      Upbeat Sanofi executives raised their full-year earnings guidance and predicted “a wave of new product launches” as the...

    6. June 8, 2014

      Chris Viehbacher shuns deal frenzy as Sanofi focuses on growth

      Chris Viehbacher is not someone who usually likes sitting on the sidelines. Known as a charismatic and dynamic leader, the...

    7. June 3, 2014

      Chief of French pharmaceuticals group Sanofi moves to US

      Sanofi scrambled to ease concern over its commitment to France on Tuesday after it was revealed that the company’s chief...

    8. April 29, 2014

      Sanofi chief executive touts organic growth strategy

      Megadeals are back in the pharmaceuticals industry but Sanofi plans to stay focused on organic growth and bolt-on...

    9. April 1, 2014

      Drugmakers learn to blend commerce with philanthropy in Africa

      Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

    10. February 12, 2014

      L’Oréal to use up excess cash by paying dividends

      L’Oréal intends to continue increasing dividend payments as the principal way to use its cash, chief executive Jean-Paul...

    11. February 6, 2014

      Sanofi and AstraZeneca prove upbeat on range of new treatments

      AstraZeneca and Sanofi trumpeted progress towards a slew of new drugs for conditions ranging from arthritis to cancer on...

    12. December 16, 2013

      French police arrest 21 in illicit horsemeat inquiry

      French police have launched raids in southern France to halt the suspected trafficking into the food chain of horsemeat...

    13. November 14, 2013

      Drug manufacturers seek to expand the range of treatments

      Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first developed,...

    14. October 30, 2013

      Sanofi: flu season

      Achoo! It is high season for flu vaccines. But you would not know it from the performance of the market leader. Sanofi’s net...

    15. October 30, 2013

      Sanofi cuts earning guidance as results miss expectations

      Vaccine shortages and slower emerging markets growth forced Sanofi to cut full-year earnings guidance as it reported...

    16. October 11, 2013

      Drug research: caring and sharing

      Which is more important – curing cancer, or malaria? Either will cost a fortune, take a long time to develop and benefit...

    17. October 2, 2013

      Johnson & Johnson: never say never

      Johnson & Johnson will never break up. Its focus on continuity is acute. The current boss has been at the company for 25...

    18. September 29, 2013

      Nestlé scrutinises its L’Oréal stake

      When Nestlé investors gather at the company’s Vevey headquarters for a two-day seminar on Monday, there will be one question...

    19. September 23, 2013

      Bribery claims infect drug companies’ dealings in China

      It began as a rumour on a Chinese social media site in July, but the impact has swiftly spread around the world: allegations...

    20. September 20, 2013

      Investment focus: Europe

      Global brands boost lure of continent Europe is finally showing signs of recovery, prompting analysts to suggest now is the...

    21. September 13, 2013

      Sanofi hints it could repurchase L’Oréal’s stake

      Sanofi, the French pharmaceuticals company, has hinted that it could repurchase L’Oréal’s 9 per cent stake in its shares if...

    22. September 4, 2013

      India approves $1.6bn acquisition of Agila Specialties by Mylan

      India’s government has given the go-ahead for US-based pharmaceutical company Mylan’s long-stalled $1.6bn acquisition of...

    23. August 30, 2013

      L’Oréal boss triggers talk of buying Nestlé’s €22bn stake

      L’Oréal tried to quash speculation that it could buy back a €22bn stake in the cosmetics maker from Swiss food group Nestlé,...

    24. August 26, 2013

      Italian stocks hit by fears of political uncertainty

      Italy’s FTSE MIB underperformed the broader pan-European FTSE Eurofirst 300 on Monday after renewed political uncertainty...

    25. August 14, 2013

      China widens probe into drug pricing and corruption

      Pressure on pharmaceutical companies operating in China intensified on Wednesday as mainland authorities announced a...

    26. August 11, 2013

      China begins probe into Sanofi whistleblower’s bribery claim

      Chinese authorities have launched an investigation into a whistleblower’s claim that staff at Sanofi bribed hospital...

    27. August 8, 2013

      Surgery needed to keep Novartis in shape

      The strength of Novartis is that it does what a big drug company should do: it makes original drugs that cure or ease the...

    28. August 8, 2013

      Novo Nordisk raises forecasts amid demand for diabetes treatments

      Novo Nordisk, the Nordic region’s most valuable company by market capitalisation, raised its sales and profit guidance for...

    29. August 8, 2013

      Chinese drugs industry inquiry widens

      Three more western pharmaceutical companies have been drawn into widening Chinese probes into pricing and marketing...

    30. August 1, 2013

      SocGen tops Eurofirst climbers on strong trading

      Société Générale topped pan-European indices after its second-quarter net profit more than doubled from a year ago thanks to...

    31. August 1, 2013

      Chinese officials visit Sanofi offices amid wider probes

      Chinese officials this week visited a regional office of Sanofi, the French pharmaceutical company, in the latest expansion...

    32. July 23, 2013

      Drug companies agree to release details of clinical studies

      European and US drug companies have agreed to share details of their clinical studies with independent researchers after...

    33. June 26, 2013

      Colruyt leads European retailers higher

      Colruyt , the Belgian supermarket retailer, was not short of support after better than expected results prompted favourable...

    34. May 27, 2013

      Biotech: it’s back

      If you are an investor in Celgene you can stop reading now. You are already on your own private island, bought with some of...

    35. May 22, 2013

      US doctors paid $1bn by top drug companies

      A dozen leading drug companies paid US doctors a total of more than $1bn last year, according to fresh data revealing the...

    36. May 16, 2013

      Inside Business: Nestlé has time to unwrap L’Oréal stake sale

      Making wasabi-flavoured KitKats for the Japanese market is one thing. Cashing in a 29.6 per cent shareholding in one of the...

    37. May 12, 2013

      Interview: Nigerian entrepreneur Charles Anudu

      Charles Anudu knew by the age of 15 that he wanted to be an entrepreneur, but it would be a decade and half before he...

    38. May 3, 2013

      Sanofi misses profit forecasts

      European austerity measures and US patent expiries helped push first-quarter earnings at Sanofi below consensus levels. The...

    Search for Sanofi and